Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis
Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity...
Gespeichert in:
Veröffentlicht in: | Cureus 2023, Vol.15 (12), p.e50050-e50050 |
---|---|
Hauptverfasser: | , , , , |
Format: | Report |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e50050 |
---|---|
container_issue | 12 |
container_start_page | e50050 |
container_title | Cureus |
container_volume | 15 |
creator | Ansari, Sahifah Zamil, Dina H Rodriguez, Edgar Dunn, Carly Kim, Soo Jung |
description | Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity that presents similarly to SJS and is described here in a patient with increased risk due to his age, chronic kidney disease, and increased dose of methotrexate. His diagnosis was complicated by other historical risk factors, including antibiotic use, but was eventually elucidated when he was noted to have bone marrow suppression. Given the pathophysiology of SJS, a T-cell mediated reaction, the patient's leukopenia increased the likelihood of MEN as his ultimate diagnosis. However, in light of his aggressive treatment and non-specific histopathology, the clinical suspicion of MEN could not be confirmed. |
doi_str_mv | 10.7759/cureus.50050 |
format | Report |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2911845566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2911845566</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_29118455663</originalsourceid><addsrcrecordid>eNqVjr0OAUEURidCQtB5gCk1uLPM7tKJnyjQ0Mtk3WXYnVlzZxKPT0KhVX3nJKf4GOsJGCaJnI6y4DDQUAJIqLFWJOJ0kIp0Uv_hJusS3QBAQBJBAi12XOo8R4fGa-W1ufAl0iOo8iOHuzZ8i6StoRmf84Ui5DbnO_RX6x0-lUe-qvQZXakKvsfMWdLUYY1cFYTd77ZZf706LjaDytlHQPKnUlOGRaEM2kCnaCre56SM4_Ef6QvqFkvB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2911845566</pqid></control><display><type>report</type><title>Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Ansari, Sahifah ; Zamil, Dina H ; Rodriguez, Edgar ; Dunn, Carly ; Kim, Soo Jung</creator><creatorcontrib>Ansari, Sahifah ; Zamil, Dina H ; Rodriguez, Edgar ; Dunn, Carly ; Kim, Soo Jung</creatorcontrib><description>Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity that presents similarly to SJS and is described here in a patient with increased risk due to his age, chronic kidney disease, and increased dose of methotrexate. His diagnosis was complicated by other historical risk factors, including antibiotic use, but was eventually elucidated when he was noted to have bone marrow suppression. Given the pathophysiology of SJS, a T-cell mediated reaction, the patient's leukopenia increased the likelihood of MEN as his ultimate diagnosis. However, in light of his aggressive treatment and non-specific histopathology, the clinical suspicion of MEN could not be confirmed.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.50050</identifier><language>eng</language><ispartof>Cureus, 2023, Vol.15 (12), p.e50050-e50050</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925</link.rule.ids></links><search><creatorcontrib>Ansari, Sahifah</creatorcontrib><creatorcontrib>Zamil, Dina H</creatorcontrib><creatorcontrib>Rodriguez, Edgar</creatorcontrib><creatorcontrib>Dunn, Carly</creatorcontrib><creatorcontrib>Kim, Soo Jung</creatorcontrib><title>Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis</title><title>Cureus</title><description>Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity that presents similarly to SJS and is described here in a patient with increased risk due to his age, chronic kidney disease, and increased dose of methotrexate. His diagnosis was complicated by other historical risk factors, including antibiotic use, but was eventually elucidated when he was noted to have bone marrow suppression. Given the pathophysiology of SJS, a T-cell mediated reaction, the patient's leukopenia increased the likelihood of MEN as his ultimate diagnosis. However, in light of his aggressive treatment and non-specific histopathology, the clinical suspicion of MEN could not be confirmed.</description><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2023</creationdate><recordtype>report</recordtype><recordid>eNqVjr0OAUEURidCQtB5gCk1uLPM7tKJnyjQ0Mtk3WXYnVlzZxKPT0KhVX3nJKf4GOsJGCaJnI6y4DDQUAJIqLFWJOJ0kIp0Uv_hJusS3QBAQBJBAi12XOo8R4fGa-W1ufAl0iOo8iOHuzZ8i6StoRmf84Ui5DbnO_RX6x0-lUe-qvQZXakKvsfMWdLUYY1cFYTd77ZZf706LjaDytlHQPKnUlOGRaEM2kCnaCre56SM4_Ef6QvqFkvB</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Ansari, Sahifah</creator><creator>Zamil, Dina H</creator><creator>Rodriguez, Edgar</creator><creator>Dunn, Carly</creator><creator>Kim, Soo Jung</creator><scope>7X8</scope></search><sort><creationdate>20231201</creationdate><title>Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis</title><author>Ansari, Sahifah ; Zamil, Dina H ; Rodriguez, Edgar ; Dunn, Carly ; Kim, Soo Jung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_29118455663</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ansari, Sahifah</creatorcontrib><creatorcontrib>Zamil, Dina H</creatorcontrib><creatorcontrib>Rodriguez, Edgar</creatorcontrib><creatorcontrib>Dunn, Carly</creatorcontrib><creatorcontrib>Kim, Soo Jung</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ansari, Sahifah</au><au>Zamil, Dina H</au><au>Rodriguez, Edgar</au><au>Dunn, Carly</au><au>Kim, Soo Jung</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis</atitle><jtitle>Cureus</jtitle><date>2023-12-01</date><risdate>2023</risdate><volume>15</volume><issue>12</issue><spage>e50050</spage><epage>e50050</epage><pages>e50050-e50050</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity that presents similarly to SJS and is described here in a patient with increased risk due to his age, chronic kidney disease, and increased dose of methotrexate. His diagnosis was complicated by other historical risk factors, including antibiotic use, but was eventually elucidated when he was noted to have bone marrow suppression. Given the pathophysiology of SJS, a T-cell mediated reaction, the patient's leukopenia increased the likelihood of MEN as his ultimate diagnosis. However, in light of his aggressive treatment and non-specific histopathology, the clinical suspicion of MEN could not be confirmed.</abstract><doi>10.7759/cureus.50050</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-8184 |
ispartof | Cureus, 2023, Vol.15 (12), p.e50050-e50050 |
issn | 2168-8184 2168-8184 |
language | eng |
recordid | cdi_proquest_miscellaneous_2911845566 |
source | PubMed Central Open Access; PubMed Central |
title | Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A34%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Differentiating%20Desquamating%20Skin%20Lesions:%20A%20Case%20of%20Methotrexate%20Epidermal%20Necrosis&rft.jtitle=Cureus&rft.au=Ansari,%20Sahifah&rft.date=2023-12-01&rft.volume=15&rft.issue=12&rft.spage=e50050&rft.epage=e50050&rft.pages=e50050-e50050&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.50050&rft_dat=%3Cproquest%3E2911845566%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2911845566&rft_id=info:pmid/&rfr_iscdi=true |